Similar articles

• Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.

  Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F. Broccard A, et al. Shock. 2000 Jul;14(1):35-40. doi: 10.1097/00024382-200014010-00007. Shock. 2000. PMID: 10909891
• Nitric oxide in the pathogenesis of sepsis.

  Symeonides S, Balk RA. Symeonides S, et al. Infect Dis Clin North Am. 1999 Jun;13(2):449-63, x. doi: 10.1016/s0891-5520(05)70085-4. Infect Dis Clin North Am. 1999. PMID: 10340177 Review.
• [Nitric-oxide synthase inhibitor treatment in septic shock].

  Møller K, Skinhøj P. Møller K, et al. Ugeskr Laeger. 2004 Mar 8;166(11):1028-9. Ugeskr Laeger. 2004. PMID: 15049244 Danish. No abstract available.
• Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red.

  Cobb JP. Cobb JP. Crit Care Med. 1999 May;27(5):855-6. doi: 10.1097/00003246-199905000-00002. Crit Care Med. 1999. PMID: 10362394 Review. No abstract available.
• Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.

  Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA. Avontuur JA, et al. Crit Care Med. 1998 Apr;26(4):660-7. doi: 10.1097/00003246-199804000-00012. Crit Care Med. 1998. PMID: 9559602 Clinical Trial.